
Oral GLP-1 Weight-Loss Pills Strain Employer Health Budgets
Even as oral GLP-1 weight-loss pills drive demand, employers worry about high upfront and ongoing costs with uncertain long‑term benefits, leading some to tighten or trim coverage for 2027; net costs to plan sponsors are around $569–$664 per employee per month after discounts, while eligibility rules tighten and some plans may avoid covering the drugs entirely, even as Medicare prices fall and competition could eventually lower prices in the longer term.


